companies - International Biopharmaceutical Industry

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Subsection - Oncology

Essential DMPK Strategies for IND Success

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

news

As biotech retreats, gene therapy companies retrench and redraw plans

Bluebird bio has spent the better part of two decades developing gene therapies for rare diseases. This summer, after years of clinical trials, setbacks and delays, t...

25 March 2022 news Biotech | companies

Continue Reading →

news

After slower-than-expected review, Pfizer and Arena close buyout deal

Dive Brief: Arena Pharmaceuticals' $7 billion sale to Pfizer closed on Friday, ending a slightly protracted regulatory review that raised questions about whether t...

14 March 2022 news Arena | companies

Continue Reading →

news

Drug, device companies gave docs, hospitals $8.4B in 2017

Doctors and teaching hospitals received $8.4 billion from drug and device companies in 2017, according to the latest Centers for Medicare and Medicaid Services Open...

6 July 2018 news $8.4B | 2017

Continue Reading →

news

Biopharmaceuticals Market Strongly guided by Companies like ABBVIE, AMGEN, BRISTOL

The market is expected to register a CAGR of 8.5% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological adva...